Showing results (651-660 of 674) with videos related to
Sort By:
Pageof 68
Cancer Chemotherapy and Pharmacology|June 20, 2006
Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)W Yeo, M Boyer, H C Chung, et al.Journal of Neurosurgery. Spine|March 2, 2006
Intrarater and interrater reliability and validity in the assessment of the mechanism of injury and integrity of the posterior ligamentous complex: a novel injury severity scoring system for thoracolumbar injuries. Invited submission from the Joint Section Meeting On Disorders of the Spine and Peripheral Nerves, March 2005James S Harrop, Alexander R Vaccaro, R John Hurlbert, et al.Clinical Pharmacology and Therapeutics|February 17, 2012
Adaptive licensing: taking the next step in the evolution of drug approvalH-G Eichler, K Oye, L G Baird, et al.Nature Cancer|February 5, 2022
Astrocytic laminin-211 drives disseminated breast tumor cell dormancy in brainJinxiang Dai, Patrick J Cimino, Kenneth H Gouin, et al.Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agentsB R Henke, S G Blanchard, M F Brackeen, et al.Scientific Reports|June 28, 2019
Mycobacterium tuberculosis whole genome sequencing provides insights into the Manila strain and drug-resistance mutations in the PhilippinesJody E Phelan, Dodge R Lim, Satoshi Mitarai, et al.Diabetes|November 8, 2013
A critical role for thioredoxin-interacting protein in diabetes-related impairment of angiogenesisLouise L Dunn, Philippa J L Simpson, Hamish C Prosser, et al.Molecular Cancer Therapeutics|April 28, 2025
PF-08046032: A novel, investigational CD25-directed antibody-drug conjugate optimized for selective depletion of regulatory T cells in advanced malignant tumorsSherif Abdelhamed, Xinqun Zhang, Weiping Zeng, et al.European Urology Oncology|March 20, 2026
Enzalutamide Plus Metformin Versus Enzalutamide Alone in Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 2 Trial (SAKK 08/14)S Gillessen, K Gobat, R Cathomas, et al.Antimicrobial Agents and Chemotherapy|October 1, 2008
Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227)Scott D Seiwert, Steven W Andrews, Yutong Jiang, et al.Pageof 68